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The responses of neutrophils to soluble and insoluble stimuli include aggre-
gation, chemotaxis, lysosomal enzyme release, and the generation of active
oxygen species such as superoxide anion . These processes, which have been
described as stimulus-response coupling, can be influenced by ions, cyclic nucleo-
tides, and metabolites of arachidonate (1) . In recent years, a role for adenosine
has been described in the stimulus-response coupling of a variety of cells and
tissues . Adenosine receptors and/or hormone like responses to adenosine have
been reported in adipocytes, neurons, hepatocytes, smooth muscle cells, coronary
arteries, and heart muscle (2-7) . These responses have also been described in
circulating cells of the blood, i.e ., lymphocytes (8-10), macrophages (11), baso-
phils (12), and mast cells (13) .
Adenosine in the presence of homocysteine thiolactone inhibits transmethyla-
tion reactions . These reactions are required for maintenance of high avidity
receptors for the chemoattractant N-formyl-methionyl-leucyl-phenylalanine
(FMLP) t on murine macrophages . Pike and Snyderman (11) found that genera-
tion of superoxide anion by macrophages in response to FMLP was inhibited by
adenosine . These studies suggested that adenosine might regulate stimulus-
response coupling in neutrophils as well . However, Marone et al . (14) were
unable to demonstrate a significant effect ofadenosine on the releaseof lysosomal
enzyme (beta-glucuronidase) from human neutrophils stimulated by particle
ingestion .
We have therefore examined the role of adenosine as a modulator of super-
oxide anion generation, degranulation, and aggregation in human neutrophils
exposed to soluble stimulants .We report that adenosine, at physiological concen-
trations, is a potent and specific regulator of neutrophil superoxide anion
generation but exerts little or no effect on either degranulation or aggregation .
Further, we demonstrate that this effect is independent of the cellular uptake of
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ADA, adenosine deaminase ; Con A, concanavalin A ; cyto C,
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forinyl-methionyl leucyl-phenylalanine ; LDH, lactate dehydrogenase ; PMA, phorbol myristate ace-
tate ; ZTS, zymosan-treated serum .
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adenosine, does not appear to depend upon inhibition of transmethylation
reactions, and is found with a variety of stimuli that activate neutrophils via
different mechanisms.
Materials and Methods
Materials.
￿
Cytochalasin B was purchased from Aldrich Chemical Co., Milwaukee, WI .
Concanavalin A (Con A), cytochrome C (cyto C) (type III), adenosine, 2-chloroadenosine,
2'-deoxyadenosine, inosine, hypoxanthine, FMLP, 1.-homocysteine thiolactone, epsilon
aminocaproic acid, xanthine oxidase (grade III from buttermilk), and calf intestinal
adenosine deaminase (ADA) (type I in ammonium sulfate) were obtained from Sigma
Chemical Co., St. Louis, MO. Zymosan was obtained from ICN Nutritional Biochemicals,
Cleveland, OH . Superoxide dismutase was obtained from Miles Laboratories, Inc., Elk-
hart, IN and dextrose (D-glucose) was obtained from Fisher Scientific Co., Fairlawn, NJ.
Calcium ionophore A23187 (A23187), and 6-nitrobenzylthioinosine were purchased from
Calbiochem-Behring Corp., San Diego, CA and phorbol myristate acetate (PMA) was
obtained from Chemalog, S. Plainfield, NJ. Erythro-9-(2-hydroxy-3-nonyl) adenine
(EHNA) was obtained from Burroughs Wellcome & Co., Research Triangle Park, NC.
(8-"C)-adenosine (50 mCi / mmol) was obtained from Schwarz/ Mann Div., Becton, Dick-
inson & Co., Spring Valley, NY. Deoxycoformycin (DCF) was a gift from Dr. J. Douros
of the National Cancer Institute. A lactate dehydrogenase (LDH) Statzyme kit was
obtained from Worthington Biochemical Corp., Freehold, NJ. DEAE cellulose chroma-
tography paper (DE 81) was supplied by Whatman Inc., Clifton, NJ.
Preparation of Cell Suspensions.
￿
Heparinized blood was obtained from normal volun-
teers. Purified preparations of neutrophils were isolated by means of Hypaque/Ficoll
gradients (15) followed by dextran sedimentation and hypotonic lysis oferythrocytes (16).
This procedure allowed studies of cell suspensions containing 98 ± 2% neutrophils with
few contaminating erythrocytes or platelets. The cells were suspended in a buffered salt
solution consisting of Na y (150 mM), K' (5 mM), Ca21 (1 .3 mM), Mg2+ (1 .2 mM), CI-
(155 mM), and Hepes (10 mM), pH 7.45. Release o£ cytoplasmic LDH was used as an
indicator ofcell death (17). Rupture ofcellsby detergent (Triton X-100) led to the release
of total LDH, beta-glucuronidase and lysozyme (17).
Preparation of Zymosan-treated Serum (ZTS).
￿
Serum was obtained from normal donors
and rendered 0.25 M with respect to epsilon aminocaproic acid. The serum was incubated
for 15 min with zymosan (I mg/ ml) at 37°C, vortexingat 5 min intervals. The suspension
was then spun at 2,000 g for 15 min and kept at 4°C until use. A final concentration of
serum of 10% was used as a stimulant in subsequent experiments (18).
Superoxide Anion Generation.
￿
Superoxide anion generation was monitored by determi-
nation of superoxidedismutase-inhibitable reduction of cyto C in the presence or absence
of cytochalasin B. Duplicate reaction mixtures containing 2 x 106 neutrophils, 75 nmol
horse heart ferricytochrome C (type III), and various inhibitory compounds (e.g., adeno-
sine) at designated concentrations in a final volume of 1 ml, were incubated for 10 min
at 37°C. Cytochalasin B (5,ug/ml) was added where indicated and cells incubated at 37°C
for an additional 5 min before exposure to stimuli (e.g., FMLP). 5 min after stimulation,
cells were spun down at 4 ° C at 1,000g in a Sorvall RC-3 centrifuge (Sorvall Instruments
Div., Dupont Co., Newtown, CT) and the supernatants were collected. Absorption at 550
nm was determined in a spectrophotometer (Model 25 ; Beckman Instruments Inc.,
Fullerton, CA) and the nanomoles of superoxide anion generated were calculated as
previously described (19).
Lvsosomal Enzyme Release.
￿
For the determination of enzyme release, neutrophils (2 x
106) were preincubated with inhibitors (e.g., adenosine) for 10 min at 37°C. Cytochalasin
B (5 Fag/ml) was then added and the mixture was incubated for an additional 5 min .
Appropriate stimulus was added to a final volume of I ml and after 5 min incubation at
37°C the cell suspensions were centrifuged at 1,000 g in a Sorvall RC-3 centrifuge for 5
min at 4°C. Aliquots of the supernatants were taken for standard determinations of beta-
glucuronidase (20) and lysozyme (21). Total enzyme activity and residual, cell-associated1162
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activity were measured in selected reaction mixtures after cells were lysed by the addition
of 0.2% Triton X-100. Appropriate control experiments were performed to determine
whether there was preferential loss of enzyme activity in resting or treated cells or whether
test reagents interfered with enzyme assays. Results are expressed as the percent of
maximally stimulated enzyme release from control cell suspensions.
Neutrophil Aggregometry.
￿
Aggregation was monitored by determining changes in light
transmission in a dual channel aggregometer (Payton Associates, Inc., Buffalo, NY) by
the method of Kaplan et al. (22). 90 Al of a suspension of neutrophils (0.25 x 106) in
buffer with designated test agent and cytochalasin B (5 ug/ml) were added to a siliconized
microcuvette with siliconized stir bar, and allowed to equilibrate a 37°C. The cells were
then stimulated with FMLP (0.1 AM) and the resulting changes in light transmission
recorded continuously over time. The extent of the aggregation was determined by
measurement of the areas under the resulting curves and is expressed as the percent of
control aggregation (FMLP stimulated aggregation in the absence of additives).
Determination of Adenosine Concentration.
￿
Supernatants of neutrophils were prepared
with and without EHNA (10 pM) and adenosine at varying concentrations, as for lysosomal
enzyme release, and analyzed immediately. Before analysis, proteins were precipitated
with 2 .1 N perchloric acid, the pH readjusted to 7.0 with 2.21 N KOH and the samples
spun in a Beckman microfuge at 4°C (900 g). Adenosine concentrations were determined
by reverse-phase high pressure liquid chromatography as previously described (23). In
brief, samples were applied to a C 18 uBondapackcolumn (Waters Associates, Inc., Milford,
MA) and eluted with a 0-40% linear gradient (formed over 60 min) of 0.01 M
ammonium phosphate (pH 5.5) and methanol, with a 1.5 ml / min flow rate. The adenosine
peak was identified by retention time, the 250/260 UV ratio of adenosine, and disap-
pearance ofthe peak after incubation with exogenous ADA (0.12 IU / ml for 2 h at 37'Q.
Determination of "C-Adenosine Uptake by Neutrophil Suspensions.
￿
(8-"C)-adenosine was
added to suspensions of neutrophils or buffer at a final concentration ranging from 0.1
to 0.5 AM . Suspensions were incubated for 10 min at 37°C, stimulated with FMLP (0.1
AM) in the presence of cytochalasin B (5 wg/ml) and supernates collected after 5 min, as
before. An equal volume of buffer or buffer containing dipyridamole (final concentration
10 AM) was added to neutrophil suspensions 5 min before the addition of labeled
adenosine. Aliquots of the supernates were lyophilized and resuspended in 50 Al of
distilled water. 20 Al of the resulting suspension was spotted on DEAE cellulose paper
with solutions of carriers (AMP, hypoxanthine, inosine, and adenosine) and descending
chromatography was performed with 1 mM ammonium formate. The carriers were
visualized under short-wave UV irradiation, cut out, placed in scintillant (PPO-POPOP
in toluene) and counted in a Beckman model LS 210 scintillation counter at ^-75%
efficiency (23).
Xonthine Oxidase-Hypoxanthine Generation ofSuperoxide Anion.
￿
Duplicate tubes contain-
ing a I -ml solution of xanthine oxidase (1 :100 dilution), hypoxanthine (2 mg/ 100 ml)
(100 nM), and ferricytochrome C (75 nM) were prepared with one of the following:
adenosine (100 AM), 2-chloroadenosine (100 AM), dipyridamole (10 AM), EHNA (10 AM),
DCF (1 AM), or ADA (0 .250 IU / ml). Tubes were incubated at 37'C for 5 min. Superoxide
generation was monitored as above and expressed as nanomoles cyto C reduced.
Preparation ofAdenosine Deaminase.
￿
30-50 Al of purified calf intestinal ADA (1,000 U /
ml) were dialyzed for at least 3 h at 4 °C against 500 ml of phosphate-buffered saline.
After dialysis the enzyme was diluted 1 :40 in buffer and 10 Al of this solution was added
to a 1 ml final volume of cell suspension . In those experiments in which ADA was
inactivated, the dialyzed enzyme was diluted 1 :40 in buffer containing DCF (100 AM).
This mixture was allowed to incubate at room temperature for at least '/2 h before use.
These conditions were found to completely inactivate the enzyme, as determined by
spectrophotometric assay (24).
Results
Exogenously Added Adenosine Inhibits Generation ofSuperoxide Anion by Neutrophils
Stimulated with FMLP. Incubation of human neutrophils with adenosine atconcentrations ranging from 1 to 1,000 AM resulted in the inhibition of super-
oxide anion generation in response to FMLP (Fig. 1). Inhibition was dose
dependent with maximal inhibition observed at 100 AM adenosine (50 ± 1%).
At higher concentrations (1,000 AM), no increase in inhibition was observed.
Significant inhibition could still be detected at 1 AM adenosine (36 ± 6%
inhibition). When inhibitors ofthe enzyme ADA (EHNA, 10 AM, or DCF, 1 AM)
wereadded together with adenosine, modestly increased inhibition ofsuperoxide
generation was observed (Fig. 1). Addition ofDCF alone had no inhibitory effect
on superoxide generation, while EHNA alone had a small but significant inhibi-
tory effect.
Concentrations of Exogenous and Endogenous Adenosine in Incubation Media of
Neutrophil Suspensions. The increased inhibition by adenosine of superoxide
generation in the presence of EHNA or DCF suggested that, in the absence of
inhibitors of ADA, exogenously added adenosine was continuously deaminated
in these suspensions. Inhibition ofADA by EHNA or DCF could have maintained
the adenosine concentration . We therefore determined concentrations of aden-
osine in the media from neutrophil suspensions that had been incubated for 15
min with adenosine in the presence or absence ofEHNA before stimulation with
FMLP (Table I). Media of cells incubated with varying concentrations of aden-
osine (1-100 AM) in the absence of EHNA all contained less adenosine than had
been added initially. When the cells were incubated with adenosine in the
presence ofEHNA, the concentrations of adenosine were higher than had been
observed in the absence of EHNA, although in most cases still less than that
added initially. Unexpectedly, when very low concentrations (0.1 AM) of adeno-
sinewere added, more adenosine was recovered than had been added, suggesting
that adenosine was being generated. Indeed, media of cells incubated without
any exogenous adenosine (both in the presence andabsence ofEHNA) contained
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FIGURE 1 .
￿
Effect of adenosine and inhibitors of ADA on generation of superoxide anion by
FMLP-stimulated neutrophils. 2 X 106 neutrophils were stimulated with FMLP (0.1 UM) in
the presence of cytochalasin B (5 jug /ml) after 15 min of incubation at 37°C with adenosine
(p), adenosine plus EHNA (10 uM) (0), or adenosine plus DCF (1 'M) (Q). Results are
expressedas mean inhibition (percent) of maximally stimulated control superoxide anion. All
points represent the mean of at least three separate determinations on cells from different
donors. The mean control generation for these experiments was 16 .4 ± 1.3 nmol cyto C-
reduced/106cells.1164 ADENOSINE: MODULATOR OF NEUTROPHIL FUNCTION
TABLE I
AdenosineConcentration in Media ofFMLP-stimulatedNeutrophils
afterIncubation in the Presence or Absence of EHNA and Adenosine
Experiment 1
￿
Experiment 2
Adenosine concentration was measured by high pressure liquid chroma-
tography as described in Materialsand Methods.
TABLE 11
Effect ofADA and Inactivated ADA (ADA + DCF) on Superoxide
Anion Generation by FMLP-stimulated Neutrophils
Percent of control
Treatment
￿
n
￿
superoxide generation
￿
P value*
(±SEM)
ADA
￿
11
￿
155 ± 18
￿
<0.006
ADA + DCF
￿
3
￿
81 ± 14
￿
NS
2 X 106cells were incubated for 10 minat 37°C with either ADA (0.25
IU/ml) or ADA incubated with its irreversible inhibitor DCF (100 AM)
for 30 min. Cells were stimulated with FMLP (0.1 juM) in the presence
of cytochalasin B. Control superoxide generation for these experiments
was 26.9 ± 5.5 nmol cyto C-reduced/ 106cells.
*P vs. control as determined by Student'st test. NS, not significant.
adenosine at concentrations ranging from 0.14 to 0.28 pM (Table I) . Similar
concentrations of adenosine were found in supernatants of cells that had not
been stimulated with FMLP (0 .17 pM).
Endogenous Adenosine Inhibits Superoxide Anion Generation by Neutrophils Stimu-
lated with FMLP. To determine whether endogenously generated adenosine
was of significance for the generation of superoxide anion, we incubated neutro-
phils with calf intestinal ADA at concentrations calculated to be in excess of
those necessary to metabolize endogenously generated adenosine. Addition of
0.125-0 .25 IU of ADA to neutrophil suspensions led to a consistent and
sometimes dramatic increase in the generation of superoxide anion by neutro-
phils (Table 11) as well as thedisappearance of endogenously generated adenosine
(Fig. 2 A). Enhancement of superoxide generation was abrogated when the ADA
was preincubated with its irreversible inhibitor DCF (100 yM) (Table I1), and
adenosine was still present in the media (Fig. 2 B) . Addition of ADA to unstim-
ulated cells did not result in superoxide anion generation (data not shown) .
Since deamination of adenosine leads to formation of hypoxanthine and
inosine, we examined theeffectsof these compoundson generation of superoxide
anion by neutrophils. Incubation of neutrophils with hypoxanthine (100 /M) or
Concentration of Concentration of adeno- Concentration of adeno-
adenosineadded sine recovered sine recovered
AM
-EHNA
tall
+EHNA -EHNA
PM
+EHNA
100.00 65.00 72.60 89.60 91 .16
10.00 3.28 8.70 7.60 10.20
1.00 0.59 0.80 0.71 1.10
0.10 0.25 0.30 0.20 0.21
0.00 0.28 - 0.14 0.18E
O
Q
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FIGURE 2.
￿
Chromatogramsof neutrophil supernatants as determined by reverse-phase high
pressure liquid chromatography. (A) Neutrophils (2 X 106)were incubatedfor 10 min at 37 °C
in the presence of 0.25 IU of ADA, then stimulated with 0.1 WM FMLP in the presence of
cytochalasin B(5 ug/ml). (B) Neutrophils (2 X 106)were treated as aboveexcept that theADA
was incubated with DCF (100 gM) before incubation with cells. Adenosineis present at afinal
concentration of 0.18 juM. The first arrow indicates time of injection, the second arrow the
elution time of authentic adenosine.
TABLE III
Effect ofMetabolites andAnalogs ofAdenosine on Superoxide Anion
Generation by FMLP-stimulatedNeutrophils
2 X 106 cells were incubated with agents for 15 min at 37°C, then stimulated
with FMLP (0.1 pM) in the presence of cytochalasin B (5 wg/ml). Control
superoxide generation for these experiments was 26.9 ± 5.5 nmol cyto C-
reduced/ 106cells.
*P vs. control as determined by Student's ttest. NS, not significant.
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inosine (100 t,M) neither increased nor diminished the generation ofsuperoxide
anion by FMLP-stimulated neutrophils (Table III).
Adenosine Inhibition of Superoxide Anion Generation is Reversible.
￿
Neutrophils
wereincubated in the presence of 100,uM adenosine for 15 min and ADA added
at varying times before stimulation with FMLP. Addition ofADA as lateas I min
before stimulation with FMLP completely eliminated inhibition of superoxide
anion generation. Enhancement of superoxide anion generation by ADA was
also independent of the duration of incubation with enzyme before stimulation
with FMLP (Table IV).
Structural Requirements for Adenosine Inhibition of Superoxide Anion Genera-
tion. To investigate the structural requirements for adenosine to inhibit gen-
eration of superoxide anion generation, the effects of two adenosine analogs
were determined. 2-Chloroadenosine, a synthetic analog modified on the purine
ring, resembled adenosine with respect to inhibition of superoxide anion gener-
ation (Fig. 3 and Table 111). Additionally, at low concentrations (0.1 t4M) similar
to endogenous adenosine concentrations, 2-Choroadenosine, which is not metab-
olized by ADA (25), reversed the enhancingeffectsofADA (98 ± 15% ofcontrol
superoxide anion generation). In contrast, 2'-deoxyadenosine, a naturally occur-
Agent (100 pM) n
Percent of control
superoxide genera-
tion (± SEM)
Pvalue*
Hypoxanthine 3 93 ± 10 NS
Inosine 3 102 ± 8 NS
2'-Deoxyadenosine 3 91 ± 10 NS
2-Chloroadenosine 5 27 ± 7 <0.00071166 ADENOSINE: MODULATOR OF NEUTROPHIL FUNCTION
TABLE IV
Effect of ADA on Superoxide Anion Generation by FMLP-stimulated Neutrophils:
Reversibility ofAdenosine Inhibition
Treatment and time before stimulation
2 X 106 cells were incubated at 37°C with agents for the indicated period of time before
stimulation with FMLP (0.1 ttM) in the presence of cytochalasin B (5 ag/ml). Superoxide
generation by cells in the absence of adenosine or ADAwas, respectively, 19.5, 31 .3, and 12.7
nmol of cyto C-reduced/ 106 cells.
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FIGURE 3.
￿
Effect of adenosine and 2-chloroadenosine on superoxide anion generation by
FMLP-stimulated neutrophils. 2 X 106 neutrophils were stimulated with FMLP (0.1 AM) in
the presence of cytochalasin B (5 rug/ml) after a 15 min incubation at 37°C with either
adenosine (A) or 2-chloroadenosine (0). All points represent the mean ofat least three separate
determinations on cells from different donors. The mean control superoxide generation for
these experiments was 26.9 ± 5.5 nmol cyto C reduced/ 106 cells.
ring analog modified in the ribose moiety, did not inhibit neutrophil generation
of superoxide anion in response to FMLP (Table III).
Effect ofAdenosine on Superoxide Anion Generation in Response to A23187, Con A,
AMA, and ZTS. To determine whether the effect of adenosine was specific to
FMLP, we examined the effect of adenosine on neutrophils stimulated by Con
A (30 tag/ml), the ionophore A23187 (5 AM), and the tumor-promoting agent
PMA (1 Ag/ml). Incubation of neutrophils with adenosine at concentrations
varying from 1 to 100 AM in the presence of EHNA (10 ,AM) led to significant
dose-dependent inhibition of superoxide anion generation stimulated by FMLP,
Con A, and A23187 (Fig. 4). Generation of superoxide anion in response to
PMA (1 Ag/ml) was much less affected by adenosine and a dose-dependent
relationship could not be demonstrated (Fig. 4). ZTS stimulated neutrophils to
Adenosine 100 juM, ^-15 min 46 18 50
Adenosine 100 jM, ^-15 min + ADA, ^-10 min 157 143 271
ADA, ^-10 min 153 139 317
Adenosine 100,uM, ^-15 min + ADA, ^-5 min 157 137 274
ADA, ^-5 min 163 142 296
Adenosine 100 AM, -15 min + ADA, ^-1 min 164 141 301
ADA, ^-1 min 164 145 294CRONSTEIN ET AL.
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FIGURE 4.
￿
Effect of adenosine plus EHNA on superoxide generation by neutrophils stimu-
lated with A23187, PMA, Con A, or FMLP. 2 X 106 neutrophils were stimulated with FMLP
(0.1 AM) (0), PMA (1 ag/ml) (EI), Con A (30 ag/ml) (0), or A23187 (5 AM)(A), in the presence
of cytochalasin B (5 Ag/ml) after a 15 min incubation at 37°C in the presence of adenosine
and EHNA (10 AM). All points represent the mean of at least three separate determinations
on cells from different donors. The mean control superoxide anion generation for these
experiments was 16.4 ± 1 .3 nmol cyto C reduced/ 106 cells for FMLP-stimulated cells, 21 .8 ±
6 nmol cyto C reduced/ 106 cells for PMA-stimulated cells, 13.9 ± 0 .7 nmol cyto C reduced/
106 cells for Con A-stimulated cells, and 16.4 ±6.5 nmol cyto C reduced/ 106 cells for A23187-
stimulated cells.
generate superoxide anion (3 .6 ± 0.7 nmol cyto C reduced/ 106 cells). Adenosine
(100 AM) plus DCF (10 AM) inhibited this response by 52 ± 10% (n = 7, P <
0.001) and ADA increased generation of superoxide anion from 134 to 319%
of control.
Adenosine Does Not Affect Neutrophils by Inhibition of Transmethylation Reac-
tions. The addition of homocysteine thiolactone (100 AM) to EHNA (10 AM)
and adenosine has previously been shown to inhibit generation of superoxide
anion by murine macrophages in response to FMLP (11). This combination of
compounds inhibited transmethylation reactions and diminished the avidity of
receptors for FMLP in these cells. Neutrophils were therefore incubated with
adenosine and EHNA (10 AM) with or without homocysteine thiolactone. In
contrast to findings in murine macrophages, the addition of homocysteine did
not increase the inhibition of superoxide anion generation over and above that
found in the presence of adenosine and EHNA alone (Fig. 5).
Cellular Uptake of Adenosine Is Not Required For Inhibition of Superoxide Anion
Generation . Dipyridamole (10 AM) inhibits adenosine transport in a variety of
cells (26) . When this agent was added to suspensions of neutrophils 5 min before
the addition of labeled adenosine (0.1 AM), uptake of labeled adenosine from
the medium by neutrophils was completely inhibited (Table V) . When higher
concentrations (0.25-0.5 AM) of labeled adenosine were added, no consistent
inhibition of uptake could be demonstrated (data not shown) . Essentially all
radioactivity counted in these supernates was present as adenosine and little or
none was found as inosine, hypoxanthine, or adenine nucleotides. Although
dipyridamole blocked uptake of adenosine from the medium, it did not appear
to inhibit efflux of adenosine from neutrophils into the medium, since the1168 ADENOSINE: MODULATOR OF NEUTROPHIL FUNCTION
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FIGURE 5.
￿
Effect of adenosine, EHNA (10 AM), and homocysteine thiolactone (100 AM)on
superoxide anion generation by FMLP-stimulated neutrophils. 2 X 106 neutrophils were
stimulated with FMLP (0.1 AM) in the presence of cytochalasin B (5 Pg/ml) after a 15 min
incubation at 37°C in the presence of adenosine plus EHNA (10 AM) (0) or adenosine plus
EHNA (10,uM) plus homocysteine thiolactone (100 KM) (0). All points represent the mean of
at least threeseparate determinations on cells from different donors. Thecontrol superoxide
anion generation forthese experiments was 16.4 ± 1.3 nmol cyto C reduced/ 106 cells.
TABLE V
Extracellular "C-Adenosine Remaining in the Medium After Incubation With
Neutrophils in the Presence and Absence ofDipyridamole
2 X 106 cells were incubated with dipyridamole (10 AM) for 5 min at 37 °C. 1 'C-
adenosine was added and the cells incubated for 10 min before stimulation with
FMLP (0.1 AM) in the presence of cytochalasin B (5 Ag/ml). Supernatants were
collected and assayed as described in Materialsand Methods.
* PMN + adenosine vs. PMN +adenosine +dipyridamole (Student's t test).
$ PMN + adenosine + dipyridamole vs. blank (Student's t test).
preincubation of neutrophils with dipyridamole led to much greater concentra-
tions of adenosine (labeled and unlabeled) in the medium (Table VI). Since
dipyridamole did not inhibit transport at higher concentrations of adenosine,
the drug does not appear to affect viability. When neutrophils were incubated
with high concentrations of adenosine (10 yM) after preincubation with dipyri-
damole (10 juM) there was no significant effect on the generation of superoxide
anion by neutrophils stimulated with FMLP (Fig. 6). At a concentration of added
adenosine at which uptake was blocked (0.1 /AM), dipyridamole significantly
enhanced the effect of adenosine on superoxide anion generation . Dipyridamole
(10 uM) had no significant effect on superoxide anion generation by neutrophils
stimulated with FMLP in the presence of buffer alone. Similarly, the enhance-
ment of superoxide anion generation found after incubation of neutrophils with
't Counts per minute
(±SEM)
Percent blank
(±SEM) Pvalue
Blank 3 3,050 ± 82
PMN + 0.1 AM adeno- 3 1,335 ± 338 45 ± 12 <0.03*
sine
PMN + 0.1 AM adeno- 3 2,791 ± 225 92 ± 7 NS$
sine + 10 AM dipyr-
ida moleTABLE V1
Adenosine Concentration in Media ofFMLP-stimulated Neutrophils
After Incubation in the Presence or Absence ofAdenosine and
Dipyridamole (DIP)
Concentration of
adenosine added
CRONSTEIN ET AL .
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Concentration of adenosine recovered
Experiment 1
￿
Experiment 2
-DIP +DIP -DIP +DIP
0.10 0.12 0.42 0.18 0.58
0.00 0.11 0.29 0.18 0.55
Neutrophils (2x 10 6 /ml) were incubated with buffer or buffer containing
dipyridamole (final concentration, 10 juM) for 5 min at 37 °C. Equal
volumes ofbuffer or buffer containing adenosine at the indicated concen-
trations were added and cells were incubated for 10 min at 37°C . Cells
were stimulated with FMLP (0 .1 uM) in the presence of cytochalasin B (5
jug/ml) . Supernatants were collected and adenosine concentration meas-
ured by high pressure liquid chromatography as described in Materials
and Methods .
FIGURE 6.
￿
Effect ofadenosineon superoxide anion generation by FMLP-stimulated neutro-
phils after blockade of adenosine uptake . 2 x 106 neutrophils were incubated for 5 min at
37 °C in buffer alone (open bar) or in the presence of dipyridamole (10 AM) (hatched bar).
Adenosine, at the indicated concentration, an equal volume of buffer, or buffer containing
ADA wasadded and cells were incubated for 10 min at 37 °C. The cells were then stimulated
with FMLP (0 .1 uM) in the presence of cytochalasin B (5 jug/ml) . Results are expressed as the
percent inhibition of control superoxide anion generation . Mean control superoxide genera-
tion for these experiments was 14.2 ± 1 .3 nmol cyto C reduced/ 106 cells and 21 .4 ± 3.8 nmol
cyto C reduced/ 106 cells for ADA-treated cells .
ADA was not affected by dipyridamole .
Adenosine Inhibits Superoxide Anion Generation in the Absence of Cytochalasin
B. Each of the previous experiments had been done in the presence of cyto-
chalasin B in order to enhance superoxide generation and lysosomal enzyme
release . Essentially similar results were obtained from experiments performed in
the absence of cytochalasin B. Adenosine inhibited generation of superoxide
anion by non-cytochalasin B-treated neutrophils stimulated with FMLP (Table
VII) . A dose-response curve of adenosine inhibition was not found in these
experiments. ADA treatment of neutrophils also produced enhancement of1170
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TABLE V11
Effect ofAdenosine and ADA on Superoxide Anion Generation by FMLP-stimulated Neutrophils
in the Presence and Absence ofCytochalasin B
2 X 106 cells were incubated for 15 min at 37°C in the presence of adenosine or ADA with and
withoutcytochalasin B (5 bg/ml) before stimulation with FMLP (0.1 AM). Mean control superoxide
anion generation in the presence of cytochalasin B was 16.4 ± 1 .3 nmol cyto C reduced/ 106 cells.
Mean control superoxide anion generation in the absence of cytochalasin B was 5.4 ± 1.4 nmol of
cyto C-reduced/106cells.
* 11vs. control as determined by Student's t test.
superoxide anion generation in the absence of cytochalasin B. Since stimulated
neutrophils generated far less superoxide anion in the absence of cytochalasin B,
the extent ofinhibition or enhancement cannot be quantitatively compared with
the results obtained in the presence ofcytochalasin B.
ADA Enhanced Superoxide Anion Generation in the Presence of Glucose.
￿
One
possible source ofendogenous adenosine in our preparations was breakdown of
intracellular ATP in neutrophil suspensions incubated without glucose. The
addition of glucose (5 mM) did not enhance superoxide anion generation by
FMLP-stimulated neutrophils. When cells were incubated with ADA in the
presence ofglucose, there was 161 ± 15% ofcontrol superoxideanion generation
(14.7 ± 4.5 nmol cyto C reduced/ 106 cells, n = 3). Cells from the same donors
incubated with ADA in the absence of glucose generated 187 ± 32% ofcontrol
superoxide anion (14.6 ± 5.0 nmol cyto C reduced/ 106 cells).
Controls for Viability and Superoxide Anion Generation.
￿
Adenosine, 2-chloro-
adenosine, and ADA had no effect on cell viability, as determined by LDH re-
lease. In threeseparateexperiments, control cellsreleased 3.0 ± 0.9%, andadeno-
sine-, 2-chloroadenosine-, and ADA-treated cells released 3.2 ± 1 .0%, 2.5 ±
1.2%, or 3.3 ± 0.7%, respectively, of total cell LDH. Nor did these three
compounds affect superoxide anion generation in the simple in vitro generating
system using hypoxanthine and xanthine oxidase. In the presence of adenosine,
2-chloroadenosine, and ADA, there was 99 ± 1, 87 ± 10, and 107 ± 3%,
respectively, of control superoxide generation (23 ± 6 nmol ofcyto C reduced).
Effect of Adenosine on Lysosomal Enzyme Release and Aggregation.
￿
Release of
lysosomal enzymes and aggregation by neutrophils in response to FMLP (0.1
j M) was much less affected by adenosine, ADA, or 2-chloroadenosine than was
the generation ofsuperoxide anion. No statistically significant effect ofadenosine
(100 , Mor 10 AM) plus EHNA (10 IAM), ADA, or 2-chloroadenosine on lysozyme
release could be demonstrated (Table VIII). Beta-glucuronidase release was
modestly inhibited by 100 uM or 10 pM adenosine plus 10 tiM EHNA as well as
by 100 juM 2-chloroadenosine (Table VIII). ADA did not have a significant effect
on beta-glucuronidase release. Neither the rate nor the extent of neutrophil
Treatment
+cytochalasin B
Percent
n
of control
Pvalue*
superoxide generation
-cytochalasin B n P value*
Adenosine 100 AM 50 ± 1 4 <0.006 29 ± 11 3 <0.015
Adenosine 10 AM 53 ± 5 4 <0.006 26 ± 11 3 <0 .015
Adenosine 1 AM 64 ± 6 5 <0.006 23 ± 8 3 <0.009
Adenosine 0.1 AM 93 ± 4 4 NS 27 ± 16 3 <0 .03
ADA 155 ± 18 12 <0.03 251 ± 23 4 <0 .015CRONSTEIN ET AL.
TABLE VIII
Effect ofAdenosine, 2-Chloroadenosine, and ADA on Release ofBeta-Glucuronidase
and Lysozyme by FMLP-stimulated Neutrophils
Discussion
2 x 106 cells were incubatedat 37°C with agents for 15 min before stimulation with
FMLP (0.1 AM) in the presence of cytochalasin B (5 ug/ml). Supernatants were
collected and assayed as described in Materialsand Methods.
* P< 0.001 vs. control as determined by Student's t test.
$ P< 0.01 vs. control (Student's ttest).
gP <0.02 vs. control (Student's t test).
TABLE IX
Effect ofAdenosine, 2-Chloroadenosine, and ADA on Aggregation ofHuman Neutrophils
Stimulated by FMLP
Percent of control aggregation
Agent
￿
Experiment I
￿
Experiment 11
1171
0.25 x 106 cells were incubated with agents in the presence or absence of cytochalasin B (cyto B) (5
jug/ml) for 3 min before stimulation with FMLP (0.1 AM). Aggregation was measured as described
in Materialsand Methods.
aggregation induced by FMLP was altered by adenosine, 2-chloroadenosine, or
ADA (Table IX).
These experiments demonstrate that adenosine preferentially inhibited gen-
eration of superoxide anion by neutrophils stimulated with FMLP, Con A,
A23187, and ZTS. The effects of adenosine were evident at concentrations
ranging from 1 to 1,000 pM with maximal inhibition at 100 AM . Cellular uptake
of adenosine was not required for adenosine-induced inhibition since inhibition
was maintained despite the addition of dipyridamole, which blocks nucleoside
uptake. Nor was deamination of adenosine required for inhibition since both
DCF and EHNA, inhibitors of ADA, did not interfere with adenosine inhibition
of superoxide anion generation. Further substantiation that the metabolism of
adenosine was not necessary for inhibition was provided by the inhibitory effect
of 2-chloroadenosine, which is not significantly metabolized (25).
The most striking finding in this study was that endogenously generated
adenosine was present in the extracellular milieu in amounts that inhibited
superoxide anion generation . Adenosine was present in the media of suspensions
Treatment rt
Percentof
Lysozyme
control release of:
Beta-glucuronidase
Adenosine 100 uM + EHNA 10 uM 4 79 ± 11 73 ± 6*
Adenosine 10 AM + EHNA 10 uM 4 99 ± 9 75 ± 9*
2-Chloroadenosine 100 AM 4 88 ± 10 70 ± 6§
ADA 4 150 ± 30 135 ± 19
+Cyto B -Cyto B +Cyto B -CytoB
Adenosine 100 uM 90 97 88 110
2-Chloroadenosine 100 AM 91 88 87 88
Adenosine deaminase 0.125 IU/ml 93 91 89 781172
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of neutrophils at concentrations of 0.1-0 .3 ,AM. Elimination of this adenosine by
incubation of cells with exogenous ADA led to marked enhancement of neutro-
phil generation of superoxide anion in response to FMLP. Since inhibition of
ADA with DCF abrogated the enhancement (and prevented degradation of
adenosine), the enhancement was not due to a nonspecificeffect of addedprotein.
Nor was this enhancement due to the generation of hypoxanthine or inosine by
the deamination of adenosine, since the addition of these compounds at 100 AM
did not affect neutrophil superoxide generation. The increase of superoxide
anion generation that we found after removal of low levels of endogenously
generated adenosine was unexpected and suggested that previous measurements
performed under similar conditions underestimated the capacity of neutrophils
to generate superoxide anion in response to various ligands.
In vivo plasma concentrations of adenosine are at least 0.3 AM (27). The
concentrations of adenosine present in plasma are greater than or equal to those
we have found in vitro in neutrophil suspensions. Since removal of these lower
concentrations of adenosine found in vitro enhanced generation of superoxide
anion by neutrophils, the concentrations of adenosine found in plasma are
sufficient to exert an inhibitory effect in vivo.
An equilibrium between cellular uptake of adenosine and efflux of adenosine
into the medium must be present in these cell preparations. Despite the disap-
pearance from the medium of more than half of the labeled adenosine added to
neutrophil suspensions, higher concentrations of adenosine than those added
were found in these supernates. Adenosine could have been released into the
extracellular medium by contaminating platelets, disrupted cells, or the intracel-
lular metabolism of ATP to adenosine. Borregaard and Herlin (28) have recently
demonstrated the presence of large concentrations of adenine nucleotides in
human neutrophils (1 .9 fmol ATP/cell). The cellular ATP concentration rep-
resents an equilibrium between catabolism to adenosine and adenine nucleotides
and phosphorylation of these compounds (0 .75 fmol ATP generated/ cell/min)
(28). These fluxes of adenosine and adenine nucleotides could result in leakage
of relatively modest amounts of adenosine into the extracellular milieu as well as
uptake of adenosine from the surrounding medium. The concentrations of
adenosine found in the extracellular medium of these suspensions represents
^-5% of the cellular ATP pool. Massive catabolism of ATP to adenosine in these
preparations was not a likely source of extracellular nucleoside since glucose, an
exogenous energy source able to prevent the large scale catabolism of ATP in
neutrophils, did not affect the ability of ADA to enhance superoxide anion
generation (29). Although, in vitro, neither platelets, disrupted cells, nor fluxes
in nucleotide metabolism were eliminated as a source of adenosine in these
preparations, in vivo, multiple tissue sources are able to contribute to adenosine
concentrations in plasma (30).
The combination of adenosine, EHNA, and homocysteine thiolactone has
been shown to inhibit transmethylation reactions in murine macrophages (11) .
Transmethylation reactions have been shown to be necessary for maintenance
of high avidity receptors for FMLP in these cells. Thus, when transmethylation
reactions were inhibited by adenosine, EHNA, and homocysteine thiolactone,
responses to FMLP, such as the generation of superoxide anion, were found toCRONSTEIN ET AL.
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be diminished. We did not find any additional effect of homocysteine thiolactone
on the generation of superoxide anion by neutrophils. Although we used con-
centrations of adenosine, EHNA, and homocysteine thiolactone that inhibit
transmethylation reactions in murine macrophages (11), we did not demonstrate
directly that transmethylation reactions were inhibited. Pike and Snyderman (31)
have also been unable to demonstrate that inhibition of transmethylation reac-
tions altered the interactions of human neutrophils with FMLP.
Our experiments suggest that adenosine exerted its effects at the cell surface,
possibly at a specific receptor, since addition of an agentshown to block adenosine
uptake did not interfere with the inhibitory effect of exogenous adenosine or
with the enhancing effect of removal of endogenous adenosine. Indeed, dipyri-
damole increased the inhibition of superoxide anion generation at a low concen-
tration of exogenous adenosine at which it completely inhibited uptake of the
nucleoside. Uptake of adenosine does not appear to be a requirement for
inhibition of neutrophil function, which is strong evidence in support of an effect
at the cell surface.
Adenosine had no effect on neutrophil aggregation or secretion of lysozyme
and only minimal effect on release of beta-glucuronidase. These experiments
indicated that adenosine did not affect the entire sequence of stimulus-response
coupling in the neutrophil but exerted, instead, a selective effect on generation
of superoxide anion generation. These findings agree with those of Marone et
al. (14) who were unable to demonstrate significant inhibition by adenosine of
beta-glucuronidase release from neutrophils that had been exposed to particles.
Based on observations in murine macrophages, Tritsch and Niswander (32,
33) have proposed that fluxes through the purine salvage pathway are essential
for the generation of superoxide anion generation. They suggested that the
activity of intracellular ADA, the primary enzyme in this pathway, was directly
correlated with and quantitatively critical for generation of superoxide anion.
Thus, an increase in the concentration of adenosine, inosine, or hypoxanthine,
the substrates in the proposed cascade, should enhance superoxide anion gen-
eration. However, we have shown that superoxide anion generation was inhibited
by adenosine and not affected by hypoxanthine or inosine. If ADA were critical
for superoxide generation, then inhibition of this enzyme should have inhibited
superoxide anion production. We demonstrated minimal inhibition of superoxide
anion generation by EHNA and no inhibition by DCF. Therefore, intracellular
fluxes through the purine salvage pathway cannot be directly involved in super-
oxide anion generation by the human neutrophil .
Although adenosine was a potent inhibitor of neutrophils stimulated by
A23187, Con A, FMLP, and ZTS, it had minimal effect on superoxide anion
generation in response to PMA. This is not surprising since PMA activates
neutrophils by mechanisms that differ from other stimuli (e.g., lack of enhance-
ment by extracellular calcium [35] and different patterns of membrane re-
modelling [35]). The data suggested that activation of the superoxide anion-
generating system by A23187, Con A, FMLP, and ZTS but not by PMA involves
an adenosine-sensitive step, the nature of which is as yet undetermined.
The most consistent explanation for ourresults is that a receptor for adenosine
is present on human neutrophils. Two major types of adenosine receptors have1174
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been described (36) . The P receptor, which is best demonstrated in cell lysates,
is active at high (millimolar) concentrations of adenosine and is specific for
adenosine analogs that have not been modified in the purine portion of the
molecule . The R receptor is active in whole cells, present in cell membranes,
active at low concentrations of adenosine, and is specific for adenosine com-
pounds that have not been modified in the ribose portion of the molecule . The
inhibition of superoxide anion generation by adenosine satisfies a number of
criteria for receptor-ligand interactions including the following : (a) adenosine
acts at the cell surface ; (b) there is a maximum inhibition achieved despite
increasing adenosine concentration, i.e ., saturability ; and (c) adenosine and 2-
chloroadenosine are equally effective inhibitors for neutrophils, whereas 2'-
deoxyadenosine is not, indicating structural specificity . The dramatic effect of
2-chloroadenosine and the lack of inhibition of neutrophils by 2'-deoxyadenosine
would argue strongly for the presence of an R receptor . We have not, as yet,
undertaken binding studies of labeled ligand to neutrophils to further investigate
this hypothesis .
The products of activated neutrophils are potentially toxic to the host . The
existence of circulating antiproteases and inactivators of active oxygen species
attests to the need for protection from inflammatory mediators released by
neutrophils . It is not surprising, therefore, that a mechanism exists to regulate
the production of superoxide anion. We have demonstrated the role of adeno-
sine, at physiological concentrations, as a specific inhibitor of superoxide anion
generation by stimulated neutrophils . We conclude that alterations of local
adenosine concentrations may influence the generation of potentially toxic
oxygen metabolites by neutrophils .
Summary
The effects of adenosine were studied on human neutrophils with respect to
theirgeneration of superoxide anion, degranulation, and aggregation in response
to soluble stimuli . Adenosine markedly inhibited superoxide anion generation
by neutrophils stimulated with N-formyl methionyl leucyl phenylalanine (FMLP),
concanavalin A (Con A), calcium ionophore A23187, and zymosan-treated
serum ; it inhibited this response to PMA to a far lesser extent . The effects of
adenosine were evident at concentrations ranging from 1 to 1,000 AM with
maximal inhibition at 100 AM . Cellular uptake of adenosine was not required
for adenosine-induced inhibition since inhibition was maintained despite the
addition of dipyridamole, which blocks nucleoside uptake . Nor was metabolism
of adenosine required, since both deoxycoformycin (DCF) and erythro-9-(2-
hydroxy-3-nonyl) adenine did not interfere with adenosine inhibition of super-
oxide anion generation . The finding that 2-chloroadenosine, which is not metab-
olized, resembled adenosine in its ability to inhibit superoxide anion generation
added further evidence that adenosine metabolism was not required for inhibi-
tion of superoxide anion generation by neutrophils . Unexpectedly, endogenously
generated adenosine was present in supernatants of neutrophil suspensions at
0.14-0.28 AM . Removal of endogenous adenosine by incubation of neutrophils
with exogenous adenosine deaminase (ADA) led to marked enhancement of
superoxide anion generation in response to FMLP . Inactivation ofADA withCRONSTEIN ET AL.
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DCF abrogated the enhancement of superoxide anion generation. Thus, the
enhancement was not due to a nonspecific effect of added protein. Nor was the
enhancement due to the generation of hypoxanthine or inosine by deamination
of adenosine, since addition of these compounds did not affect neutrophil
function . Adenosine did not significantly affect either aggregation or lysozyme
release and only modestly affected beta-glucuronidase release by neutrophils
stimulated with FMLP. These data indicate that adenosine (at concentrations
that are present in plasma) acting via cell surface receptors is a specific modulator
of superoxide anion generation by neutrophils.
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